Bahram Valamehr - 14 Mar 2022 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
Chief R&D Officer
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
Issuer symbol
FATE
Transactions as of
14 Mar 2022
Net transactions value
-$708,483
Form type
4
Filing time
15 Mar 2022, 16:27:17 UTC
Previous filing
27 Jan 2022
Next filing
07 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $68,250 +25,000 +14% $2.73 204,834 14 Mar 2022 Direct F1
transaction FATE Common Stock Sale $506,344 -16,678 -8.1% $30.36* 188,156 14 Mar 2022 Direct F1, F2
transaction FATE Common Stock Sale $97,101 -3,067 -1.6% $31.66* 185,089 14 Mar 2022 Direct F1, F3
transaction FATE Common Stock Sale $71,316 -2,195 -1.2% $32.49* 182,894 14 Mar 2022 Direct F1, F4
transaction FATE Common Stock Sale $98,568 -2,960 -1.6% $33.30* 179,934 14 Mar 2022 Direct F1, F5
transaction FATE Common Stock Sale $3,404 -100 -0.06% $34.04* 179,834 14 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -25,000 -41% $0.000000 36,156 14 Mar 2022 Common Stock 25,000 $2.73 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020.
F2 Represents the weighted average sale price of the shares sold from $30.00 to $30.98 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 5.
F3 Represents the weighted average sale price of the shares sold from $31.00 to $31.99 per share.
F4 Represents the weighted average sale price of the shares sold from $32.00 to $32.99 per share.
F5 Represents the weighted average sale price of the shares sold from $33.00 to $33.91 per share.
F6 This option is fully vested.